Transmission dynamics and fitness of reemerging St. Louis encephalitis virus
Transmission dynamics and fitness of reemerging St. Louis encephalitis virus
批准号:
10645668
负责人:
Lark L Coffey
金额:
$24.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-03 至 2025-06-30
关键词:
AreaArizonaBiological AssayBirdsBloodCaliforniaCell Culture TechniquesCellsCompetenceComplementCountyCulex (Genus)Culex pipiensCulicidaeDiseaseDisease OutbreaksDoseDucksEmbryoEncephalitisEnvironmentEpidemicExhibitsExtinctionFeverFibroblastsFlavivirusGeneticGenetic studyGenotypeGeographyGoalsHerd ImmunityHumanImmunityIncubatedInfectionInfectious EncephalitisIngestionInvadedLearningMeasuresMediatingPatternPersonsPlayProcessResource AllocationRoleSalivaSamplingSouth AmericaSt. Louis Encephalitis VirusTestingTimeTissuesViralVirusVirus DiseasesWest Nile virusenhancing factorenzooticfitnesshuman pathogenimprovedmosquito-bornemosquito-borne pathogennovelnovel strategiestransmission processvectorvector competencevector controlvector mosquitoviral RNAviral fitnessviral transmissionvirus genetics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
St. Louis encephalitis virus (SLEV) is a mosquito borne pathogen that causes febrile illness and sometimes
fatal encephalitis and was a leading cause of infectious encephalitis in the US during the 1970s. After an 11-
year absence in activity in California, SLEV reemerged and reestablished in CA from 2015-2021, and caused
an outbreak in nearby Phoenix, AZ. SLEV reemergence is marked by increasing human cases and positive
mosquito pools across more counties each year, including areas with concurrent activity of West Nile virus
(WNV), a related flavivirus that invaded CA in 2003 and which shares avian reservoirs and Culex mosquito
vectors with SLEV. Genetic tracing by our team showed that reemerging (‘contemporary’) SLEV in the Western
US is genetically distinct from pre-2003 (‘historical’) SLEV and that it likely originated in South America.
However, other than these studies, drivers of SLEV reemergence, including into WNV-endemic areas, have
not been examined. Spread of WNV across the US was facilitated by augmented avian reservoir infection and
vector competence. We propose that similar fitness gains may have enabled SLEV reemergence. The
objective of this project is to assess the extent by which SLEV reemergence is promoted by augmented
infectivity and transmissibility in mosquito and avian cells and mosquito vectors. Higher SLEV activity in
different regions may be explained by differential vector competence for 3 primary Culex vectors (pipiens,
tarsalis, and quinquefasciatus) that favor different environments across the state. We hypothesize that SLEV
reemergence in the Western US since 2015 was mediated by augmented fitness of the introduced genotype in
cells and vectors and that geographic localization is influenced by relative vector competence of 3 primary
Culex species. Viral fitness can be assessed experimentally by comparing SLEV strains using vector
competence and competition assays. The project hypotheses will be tested in 2 project Aims: 1) Determine
transmission competence of contemporary versus historical SLEV in Culex vectors, and 2) Compare relative
fitness of contemporary versus historical SLEV in avian and mosquito cells and vectors. This project is
significant in that it will provide a unique opportunity to compare viral factors involved in the sequential invasion
and spread of 2 Culex-borne flaviviruses, where understanding co-circulation dynamics can be applied to other
sympatric flaviviruses. By defining the role Culex vector species play in SLEV transmission this project will
determine whether augmented infectivity and transmissibility is a factor enhancing reemergence and spread.
To reduce disease, vector control districts can allocate resources towards spatial targeting of the Culex vector
species that exhibit high SLEV competence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Collaborative cross mice as a new model for diverse human outcomes of St. Louis encephalitis virus disease
-
批准号:10726431
-
项目类别:
-
资助金额:$25.32万
-
财政年份:2023
-
负责人:Lark L Coffey
-
依托单位:
Engineering high fidelity mutations to increase safety of live-attenuated alphavirus vaccines
-
批准号:9160799
-
项目类别:
-
资助金额:$44.87万
-
财政年份:2016
-
负责人:Lark L Coffey
-
依托单位:
Engineering high fidelity mutations to increase safety of live-attenuated alphavirus vaccines
-
批准号:9925764
-
项目类别:
-
资助金额:$53.83万
-
财政年份:2016
-
负责人:Lark L Coffey
-
依托单位:
Engineering high fidelity mutations to increase safety of live-attenuated alphavirus vaccines
-
批准号:9300831
-
项目类别:
-
资助金额:$54.19万
-
财政年份:2016
-
负责人:Lark L Coffey
-
依托单位:
海外基金